Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara A. Murphy, MD
Vanderbilt-Ingram Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Georgia Hematology Oncology Associates, P.C.
Macon, Georgia, United States
- Erlanger Health System
Chattanooga, Tennessee, United States
- Jackson-Madison County Hospital
Jackson, Tennessee, United States
- East Tennessee State University
Johnson City, Tennessee, United States
- Center for Biomedical Research
Knoxville, Tennessee, United States
- Meharry Medical College
Nashville, Tennessee, United States
- Va Tennessee Valley Healthcare Center
Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2002
- Primary completion
- 31 May 2007
- Completion
- 31 Jul 2008
- Last update posted
- 14 Sept 2012
- Registered enrollment
- 41
- Registry id
- NCT00639769
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.